Verdun, CA, United States of America

Claude A Piche

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Amphastar Pharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claude A Piche. Retrieved from https://idiyas.com/inventor/claude-a-piche-iqur0fbs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0



Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claude A. Piche: Innovator in Nasal Powder Formulation for Hypoglycemia Treatment

Introduction

Claude A. Piche is a notable inventor based in Verdun, Canada. He has made significant contributions to the field of medical formulations, particularly in the treatment of hypoglycemia. His innovative approach has led to the development of a unique nasal powder formulation that offers a new method for administering glucagon.

Latest Patents

Claude A. Piche holds a patent for a nasal powder formulation designed for the treatment of hypoglycemia. This formulation contains glucagon or a glucagon analog, which is useful in managing severe hypoglycemia. The patent also outlines a method for creating this powder formulation, along with devices and methods for its application. He has 1 patent to his name.

Career Highlights

Piche is currently associated with Amphastar Pharmaceuticals, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in formulation development has positioned him as a valuable asset to the company.

Collaborations

One of his notable coworkers is Jo Jan Filip Van Betsbrugge, with whom he collaborates on various projects within the company.

Conclusion

Claude A. Piche's work in developing a nasal powder formulation for hypoglycemia treatment exemplifies his commitment to innovation in the medical field. His contributions are paving the way for more effective treatment options for patients suffering from this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…